ABSTRACT
Helicobacter cinaedi is an emerging opportunistic pathogen associated with infections of diverse anatomic sites. Nevertheless, the species demonstrates fastidious axenic growth; it has been described as requiring a microaerobic atmosphere, along with a strong preference for supplemental H2 gas. In this context, we examined the hypothesis that in vitro growth of H. cinaedi could be enhanced by coculture with human epithelial cells. When inoculated (in Ham's F12 medium) over Caco-2 monolayers, the type strain (ATCC BAA-847) gained the ability to proliferate under H2-free aerobic conditions. Identical results were observed during coculture with several other monolayer types (LS-174T, AGS, and HeLa). Under chemically defined conditions, 40 amino acids and carboxylates were screened for their effect on the organism's atmospheric requirements. Several molecules promoted H2-free aerobic proliferation, although it occurred most prominently with millimolar concentrations of l-lactate. The growth response of H. cinaedi to Caco-2 cells and l-lactate was confirmed with a collection of 12 human-derived clinical strains. mRNA sequencing was next performed on the type strain under various growth conditions. In addition to providing a whole-transcriptome profile of H. cinaedi, this analysis demonstrated strong constitutive expression of the l-lactate utilization locus, as well as differential transcription of terminal respiratory proteins as a function of Caco-2 coculture and l-lactate supplementation. Overall, these findings challenge traditional views of H. cinaedi as an obligate microaerophile.
IMPORTANCE H. cinaedi is an increasingly recognized pathogen in people with compromised immune systems. Atypical among other members of its bacterial class, H. cinaedi has been associated with infections of diverse anatomic sites. Growing H. cineadi in the laboratory is quite difficult, due in large part to the need for a specialized atmosphere. The suboptimal growth of H. cinaedi is an obstacle to clinical diagnosis, and it also limits investigation into the organism's biology. The current work shows that H. cinaedi has more flexible atmospheric requirements in the presence of host cells and a common host-derived molecule. This nutritional interplay raises new questions about how the organism behaves during human infections and provides insights for how to optimize its laboratory cultivation.
INTRODUCTION
Helicobacter cinaedi is an emerging pathogen of the class Epsilonproteobacteria. This spiral-shaped Gram-negative rod is associated with opportunistic infections of multiple anatomic sites, including the intestinal tract (1, 2), blood (3, 4), peripheral soft tissue (5, 6), and other body fluids (7–9). This behavior contrasts with related Helicobacter and Campylobacter species, which typically demonstrate a more limited tissue tropism. H. cinaedi was identified ∼30 years ago in men who have sex with men (1) and HIV patients (10, 11), although infections have since been described in other immunocompromised groups (12, 13), as well as immunocompetent (14–17) and postsurgical patients (18).
Despite abundant case reports, the ecology/epidemiology of H. cinaedi remains poorly defined and sparsely studied. Limited molecular evidence suggests that it can be found in the stools of a small percentage of healthy individuals (19). The organism has also been isolated from animal feces (including rodents, dogs, and primates), although its role as a veterinary and/or zoonotic pathogen is uncertain (20, 21). An environmental reservoir has not yet been identified. The majority of recent literature on H. cinaedi (for instance, many of the current references) originates from Japan, although it is unclear whether this reflects regional prevalence or an increased awareness among Japanese investigators. Knowledge of H. cinaedi biology and tools for its genetic manipulation are likewise sparse, limited to several studies of targeted deletion mutants. These deletion mutants include strains deficient in cytolethal distending toxin (22) and alkyl hydroperoxide reductase (23), both of which demonstrate attenuated virulence in a murine colitis model.
Likely contributing to this paucity of information, H. cinaedi is a challenging organism to manipulate in vitro. Strains are notable for poor, film-like growth on agar plates, a preference for biphasic culture (broth over agar), and decreased viability on subculture (24, 25). Recommended medium conditions for H. cinaedi are not standardized. Various formulations have been utilized (e.g., brucella broth/agar, brain heart infusion, tryptic soy, and CDC anaerobic media), both with and without supplemental blood/serum products (20, 26). In a recent study, Levinthal broth (Mueller-Hinton broth with horse serum) was proposed as a favorable medium for susceptibility testing of clinical isolates (20). H. cinaedi is considered microaerophilic, like many members of the class Epsilonproteobacteria, and demonstrates a strong preference for H2 gas (24, 27, 28). The latter phenomenon is presumably due to H2 serving as a respiratory electron donor (29), although this mechanism has not been demonstrated explicitly. The large majority of recent published work on H. cinaedi has employed H2-enhanced microaerobic conditions (which, notably, are not available within all diagnostic/research laboratories). Even with this favorable atmosphere, the organism is characterized by slow growth and attains low optical density in liquid culture (26).
Given this fastidious behavior, the ability of H. cinaedi to proliferate under aerobic or H2-free conditions has never been investigated systematically. Nevertheless, several indirect lines of evidence suggest that H. cinaedi may possess more flexible atmospheric requirements than traditionally assumed. As mentioned above, the species has been associated with infections of diverse anatomic sites (stool, blood, and tissue), which can demonstrate a broad range of in situ gas concentrations (29). Moreover, the ability of clinical laboratories to propagate H. cinaedi with typical blood culture platforms implies at least some degree of aerotolerance. Although agar subculture of blood bottles (for colonial isolation/identification of H. cinaedi) requires microaerobic conditions (30, 31, 32), the initial bottles are neither microaerobic nor H2-supplemented. Rather, microbial growth in commercial systems is detected under a fixed aerobic or anaerobic atmosphere (33). When explicitly reported, H. cinaedi has been detected overwhelmingly in aerobic blood culture bottles (30, 34).
In this context, we sought to better define the growth dynamics of the type strain (ATCC BAA-847) under various conditions of monoculture and epithelial coculture. This work demonstrated that epithelial monolayers and l-lactate facilitate H. cinaedi growth under H2-free aerobic conditions. These findings were confirmed for a collection of clinical H. cinaedi isolates, and the transcriptional behavior of the type strain was characterized by high-throughput RNA sequencing (RNA-seq) under diverse growth conditions, including epithelial coculture and l-lactate supplementation. In total, this study demonstrates that the atmospheric requirements of H. cinaedi are not fixed but rather are interconnected with other nutritional and environmental factors. These findings are relevant for developing improved methods of isolating/propagating H. cinaedi in the laboratory and raise important questions about how the species behaves in infected tissue and blood.
MATERIALS AND METHODS
Bacterial strains and cell lines.
H. cinaedi ATCC BAA-847T, originally isolated from a human rectum, was acquired from the American Type Culture Collection (1, 35). Other clinical isolates of H. cinaedi were obtained from the laboratories of Naoaki Misawa (University of Miyazaki) and James Fox (Massachusetts Institute of Technology); see Table 1 for additional information. Commercially available human epithelial cell lines used in this study included Caco-2 (colorectal adenocarcinoma, enterocyte-like), LS-174T (colorectal adenocarcinoma, goblet cell like), AGS (gastric adenocarcinoma), and HeLa (cervical adenocarcinoma).
TABLE 1.
Strains of H. cinaedi employed in this study
| H. cinaedi strain | Sitea | Reference |
|---|---|---|
| ATCC BAA-847 | Rectal | 35 |
| CCUG 18818 | Rectal | 61 |
| N66 | Blood | 21 |
| N69 | Blood | 21 |
| N70 | Blood | 21 |
| N71 | Blood | 21 |
| N73 | Blood | 21 |
| N76 | Blood | 21 |
| N77 | Blood | 21 |
| S1 | Blood | 21 |
| S3 | Blood | 21 |
| S5 | Blood | 21 |
| S8 | Blood | 21 |
Anatomic site of original isolation.
Bacterial monoculture.
Bacterial monoculture experiments were performed at 37°C in either (i) Ham's F12 medium (F12) (GE HyClone), a chemically defined medium previously shown to support H. cinaedi growth (24); (ii) Mueller-Hinton broth (Sigma-Aldrich), a predominantly casein-based medium; (iii) brucella broth (BD BBL), a tissue/casein-based medium; or (iv) brain heart infusion broth (Oxoid), a tissue/peptone-based medium. (Complete formulations of each are provided in Table 2.) As indicated, media were supplemented with various metabolites (see below), 10% fetal bovine serum (FBS), or normal human serum (Atlanta Biologicals). Bicarbonate-free F12 (Thermo HyClone) supplemented with HEPES (10 mM; pH 7.2) was utilized for experiments conducted under CO2-free aerobic conditions. H2-supplemented microaerobic conditions were achieved through the Bio-Bag type A environmental chamber (BD), with omission of the palladium catalyst (27); this technology relies upon direct evolution of H2 (with resultant dilution of O2) through a KBH4-HCl reaction. H2-free/CO2-supplemented microaerobic conditions were achieved through GasPak EZ Campy sachets (BD), which utilize activated charcoal/ascorbic acid to generate CO2 from O2 (36). CO2 supplementation (5% CO2) was employed for aerobic conditions. For anaerobic conditions, GasPak EZ anaerobic sachets (BD) and Bio-Bag type A chambers (with palladium catalyst) were employed.
TABLE 2.
Liquid culture media employed in this study
| Medium | Component(s) | Concna |
|---|---|---|
| Ham's F12 mediumb | l-Arginine and l-glutamine | 1 mM |
| l-Proline | 0.3 mM | |
| l-Cysteine | 0.2 mM | |
| l-Isoleucine, l-methionine, l-phenylalanine, and l-tyrosine | 0.03 mM | |
| l-Tryptophan | 0.01 mM | |
| l-Lysine | 0.12 mM | |
| Glycine, l-alanine, l-asparagine, l-aspartic acid, l-glutamic acid, l-histidine, l-leucine, l-serine, l-threonine, and l-valine | 0.1 mM | |
| Biotin | 3E−05 mM | |
| Choline chloride | 0.1 mM | |
| Ca pantothenate | 0.001 mM | |
| Folic acid | 0.003 mM | |
| Niacinamide | 3E−04 mM | |
| Pyridoxine HCl | 2.9E−04 mM | |
| Riboflavin | 9.8E−05 mM | |
| Thiamine HCl | 8.9E−04 mM | |
| Vitamin B12 | 0.001 mM | |
| meso-Inositol | 0.1 mM | |
| CaCl2 | 0.3 mM | |
| CuSO4 | 1E−05 mM | |
| FeSO4 and ZnSO4 | 0.003 mM | |
| MgCl2 | 0.6 mM | |
| KCl | 3 mM | |
| NaCl | 131 mM | |
| Na2HPO4 | 1 mM | |
| d-Glucose | 10 mM | |
| Na hypoxanthine | 0.03 mM | |
| Linoleic acid | 4E−04 mM | |
| Lipoic acid | 0.001 mM | |
| Phenol red | 0.003 mM | |
| Putrescine 2HCl | 0.001 mM | |
| Sodium pyruvate | 1 mM | |
| Thymidine | 0.003 mM | |
| Mueller-Hinton broth | Casein hydrolysate | 17.5 g/liter |
| Beef infusion solids | 2 g/liter | |
| Starch | 1.5 g/liter | |
| Brucella broth | Casein, pancreatic digest | 10 g/liter |
| Animal tissue, peptic digest | 10 g/liter | |
| Dextrose | 1 g/liter | |
| Yeast extract | 2 g/liter | |
| NaCl | 5 g/liter | |
| Sodium bisulfite | 0.1 g/liter | |
| Brain heart infusion broth | Brain infusion solids | 12.5 g/liter |
| Beef heart infusion solids | 5 g/liter | |
| Proteose peptone | 10 g/liter | |
| Dextrose | 2 g/liter | |
| NaCl | 5 g/liter | |
| Disodium phosphate | 2.5 g/liter |
The concentration for each component of Ham's F12 medium is shown (e.g., 1 mM for l-arginine and 1 mM for l-glutamine).
Note that two different buffering systems were used for Ham's F12 medium, depending on the experimental conditions (see Materials and Methods), either bicarbonate (14 mM) or HEPES (10 mM).
Aerobic growth promotion screen.
Amino acid and carboxylate additives were acquired from Sigma-Aldrich; the stock solution pH was adjusted (7.0 to 7.2) prior to bacterial supplementation. Following initial culture in F12 under H2-supplemented microaerobic conditions, bacteria were subcultured (optical density at 600 nm [OD600] of 0.01) into F12 medium supplemented with each supplement(s). Growth was assessed by optical density after 24 h of incubation under H2-free/CO2-supplemented microaerobic conditions. Each culture was then rediluted to an OD600 of 0.01 in the same supplemented F12 and incubated for an additional 24 h under CO2-supplemented aerobic conditions. OD600 was then measured again to evaluate promotion of aerobic growth.
Bacterial/monolayer coculture.
Epithelial cells were initially propagated (37°C, 5% CO2) in Eagle's minimal essential medium (Corning) with 10% fetal bovine serum, l-glutamine (2 mM), and penicillin-streptomycin. When freshly confluent, immediately prior to bacterial inoculation, the monolayers were washed three times in F12 without serum or antibiotics. Prior to coculture, H. cinaedi (both the type strain and clinical isolates) were propagated in F12 under H2-enhanced microaerobic conditions. The bacteria were then directly subcultured to an OD600 of 0.01 onto the washed monolayers in F12 under the atmosphere of interest (10 ml per 25-cm2 tissue culture flask) at an initial bacterial cell/epithelial cell ratio of ∼100:1. Bacterial growth was assessed by OD600 measurement at 24 h, as neither dissociation nor overgrowth of the monolayer was evident at this time point for all cell types (at longer times, overgrowth/dissociation of monolayer was occasionally observed).
Viability staining.
During growth curve analysis of H. cinaedi BAA-847T, bacterial viability was assessed using the BacLight bacterial viability kit (Molecular Probes). This method was employed due to the strain's poor colony-forming ability, precluding reliable CFU-based viability determination. Propidium iodide (final concentration, 30 nM) and SYTO-9 (final concentration, 5 nM) were added directly to liquid cultures and visualized under fluorescence excitation at a magnification of ×1,000 (Meiji Techno MT6000 microscope; Chroma 19002 and 19004 filters). Green- and red-staining bacteria were interpreted as viable and nonviable, respectively (500 organisms counted per replicate).
mRNA sequencing.
H. cinaedi BAA-847T was diluted to an initial OD600 of 0.01 for all media/atmospheric conditions, with the exception of H2-free/CO2-supplemented microaerobic growth in F12 medium, for which an initial OD600 of 0.025 was used (given the organism's poor growth under these conditions). Following 24 h at 37°C, 2 volumes of RNA fixative (RNAprotect bacterial reagent; Qiagen) were added directly to the cultures. Bacteria were pelleted and preincubated (10 min, 65°C) with Max bacterial RNA enhancement reagent (Ambion). Total RNA was subject to TRIzol extraction; RNA quality was confirmed by 260/280 absorbance (Nanodrop) and 23S/16S rRNA ratios (Agilent Bioanalyzer). rRNA was subsequently depleted through the Gram-negative Ribo-Zero rRNA removal kit (Epicenter), and a cDNA library was constructed for Illumina sequencing through the TruSeq Stranded mRNA library prep kit (Illumina). The library was subjected to 50-bp paired-end sequencing on the Illumina HiSeq 2000 instrument at the Vanderbilt University genomics core facility (Vanderbilt Technologies for Advanced Genomics). Reads were aligned to the organism's genome (35) and quantified (total read counts and RPKM [reads per kilobase transcript per million reads] values) with the EDGE-pro software package (37), accessed online via the Orione Galaxy Server (38). For each biologic replicate, 18.9 to 25.8 million aligned reads were obtained. RNA-seq data were visualized as heatmaps using the R environment for statistical computing v3.3.0 (39) and the gplots analysis package (40).
Statistical analysis.
Bacterial optical density measurements were compared across culture conditions using an unpaired two-tailed Student's t test. In RNA-seq experiments, the relative abundance of each transcript was compared through DESeq2 (41). This R software package utilizes total read counts (generated here by EDGE-pro) to calculate an adjusted P value, a parameter that considers these values in light of the genomic size. Covariance analysis of RPKM values was conducted in R, with Pearson coefficients and correlation P values calculated through the HMisc package (42). Hierarchical clustering and image generation was also performed with the latter package (heatmap.2 algorithm).
Accession number(s).
For all RNA-seq experiments, raw reads (paired FASTQ files) and processed data (total assigned reads and RPKM values) have been uploaded to ArrayExpress, with accession number E-MTAB-5062. Statistical metadata for transcriptional coexpression analysis are available via figshare (https://figshare.com/articles/H_cinaedi_Pearson_Matrix_csv/3749190).
RESULTS
H. cinaedi monoculture.
In this study, we sought to define how the in vitro growth of H. cinaedi is impacted by variations in media, atmosphere, and the presence of cocultured epithelial monolayers. As a reference point for these experiments, liquid-phase growth curves were first determined for the type strain (ATCC BAA-847) under a known favorable atmosphere, H2-enhanced microaerobic atmosphere. Optical density was assessed for monocultured bacteria in three complex media (Mueller-Hinton broth [MHB], brucella broth [BB], and brain heart infusion broth [BHI]) and one chemically defined medium (Ham's F12). In these experiments, bacteria initially proliferated with an ∼4-h doubling time (Fig. 1A), reaching a maximum density of OD600 of 0.06 for F12 and 0.25 to 0.35 for the complex broth media. With all media, bacterial viability decreased markedly once maximum density was achieved (as determined by SYTO-9/propidium iodine staining; see the legend to Fig. 1 for additional details). Based on these curves, subsequent experiments were conducted over 24 to 48 h with an initial OD600 of 0.01 (or ∼3.5 × 107 cells/ml, per counting chamber calculation).
FIG 1.
In vitro growth of H. cinaedi ATCC BAA-847T. (A) Bacterial growth curves. Optical density (OD600) was assessed for up to 96 h for bacteria grown in one chemically defined medium (Ham's F12 medium [F12]) and three complex media (brucella broth [BB], brain heart infusion broth [BHI], and Mueller-Hinton broth [MH]), each under H2-supplemented microaerobic conditions. A starting OD600 of 0.005 was employed for each replicate; mean OD600 values ± standard deviations (error bars) (n = 4) are plotted. For later time points, bacterial viability was assessed by SYTO-9/propidium iodide staining and fluorescence microscopy. Although maximum achievable density varied between medium types, bacterial viability decreased markedly in each case once this maximum density was reached. The following mean viabilities were observed for each medium and time point as follows: for F12, 91.5% at 16 h, 56% at 48 h, and 18.5% at 72 h; for BB, 98.4% at 48 h, 54.1% at 72 h, and unable to quantify due to ubiquitous bacterial fragmentation at 96 h; for BHI, 99.1% at 48 h, 55.7% at 72 h, and unable to quantify as before at 96 h; for MH, 98.5% at 48 h, 95.2% at 72 h, and unable to quantify as before at 96 h. Ninety-six-hour analysis was omitted for F12 due to nonviability at 72 h. (B) Variations in F12 medium. Bacteria were grown in F12 medium with variations in key culture parameters. The variations in culture parameters include either monophasic (Mono) or biphasic (Bi) F12, with (Y) or without (N) 10% supplemental FBS, and in one of three atmospheres. The atmosphere or gas conditions were as follows: 1, CO2-supplemented aerobic; 2, H2-free/CO2-supplemented microaerobic; 3, H2-supplemented microaerobic. The initial inoculum is indicated by the arrow labeled Inoc. In each case (n ≥ 4), an initial inoculation density of OD600 of 0.01 was employed (as indicated), with 24- and 48-h optical density depicted here. Values that are significantly different (P < 0.01) at both 24 and 48 h are indicated by a bar and asterisk. Note the prominent error bars (indicated by the number sign) for serum-supplemented aerobic conditions, indicative of growth in certain replicates but static density in others. (C) Variations in complex media. Culture parameters were likewise varied for MH, BB, and BHI, including 10% FBS supplementation and atmosphere (n ≥ 4) (same abbreviations as in panel B). All conditions represent monophasic growth. For the sake of clarity, designations of statistical significance are not included, although growth in atmosphere 3 > growth in atmosphere 2 > growth in atmosphere 1 for all media. Prominent error bars (indicated by the number sign) again highlight growth in certain replicates—but static density in others—for aerobic, serum-supplemented BB. (D) Epithelial coculture. H. cinaedi was inoculated directly onto Caco-2 epithelial cells and incubated under CO2-supplemented aerobic (O2 + CO2) or H2-supplemented microaerobic (mO2 + H2) conditions. Bacteria were likewise inoculated over LS-174T, AGS, and HeLa cells and incubated under CO2-supplemented aerobic conditions. Bacterial densities at 24 h are summarized here (n ≥ 4). For each monolayer type, epithelial coculture permitted aerobic proliferation of the bacteria. No aerobic growth was observed for monolayer-free conditions (X). *, P < 0.001.
For each of the above media, culture parameters were varied to determine their effect on H. cinaedi proliferation. Three atmospheres were compared: H2-supplemented microaerobic, H2-free/CO2-supplemented microaerobic, and CO2-supplemented aerobic. In each case, H. cinaedi was first propagated under H2-supplemented microaerobic conditions, followed by subculture in the atmosphere of interest and assessment of growth. For F12 medium, monophasic growth (liquid alone) in each atmosphere was compared to biphasic growth (liquid over agar) and serum-supplemented growth (F12 plus 10% FBS). As depicted in Fig. 1B, biphasic F12 medium led to higher bacterial density under H2-supplemented microaerobic conditions (relative to monophasic), although it was not associated with increased growth under H2-free/CO2-supplemented microaerobic conditions or with any growth under aerobic conditions. In contrast, the presence of serum enhanced bacterial proliferation in F12 under all three atmospheres, including (most notably) aerobic growth. The effect of serum under aerobic conditions was inconsistent, however, as aerobic growth was present in certain serum-supplemented replicates but absent in others.
Similar experiments were conducted in complex media (MHB, BB, and BHI) under the same three atmospheres, both with and without 10% FBS (Fig. 1C). As expected, H2 supplementation uniformly increased bacterial growth under microaerobic conditions. Likewise, serum supplementation of complex media enhanced microaerobic growth, and once more, it facilitated occasional H. cinaedi proliferation under aerobic conditions. Nevertheless, the effect was again inconsistent: aerobic growth was limited to serum-supplemented BB (not BHI/MHB) and was variable from one replicate to the next. Together, the above findings indicate that H. cinaedi will occasionally grow aerobically in the presence of serum, although other environmental or stochastic factors likely influence this ability. The behavior, in fact, is reminiscent of the isolation of H. cinaedi from aerobic blood culture bottles; the latter is a well-described phenomenon in clinical settings, albeit one that occurs with noteworthy interlaboratory variability (30, 34).
H. cinaedi coculture with epithelial cells.
The preceding observations led us to hypothesize that one or more host-derived factors present in serum were responsible for promoting aerobiosis in H. cinaedi. Therefore, the organism's growth was next evaluated during coculture with epithelial monolayers. The type strain was inoculated in serum-free F12 medium over freshly confluent Caco-2 intestinal cells. Compared to monocultured bacteria, the cocultured bacteria not only grew to higher densities under microaerobic conditions, but they consistently proliferated in a CO2-supplemented aerobic environment (Fig. 1D). The ability of epithelial cells to promote H2-free aerobic growth of H. cinaedi ATCC BAA-847T was not limited to Caco-2 monolayers. The same phenomenon occurred with several other gastrointestinal and nongastrointestinal cell lines (LS-174T, AGS, and HeLa [Fig. 1D]), as well as polarized Caco-2 cells from mature Transwell cultures (more than 2 weeks [data not shown]). Caco-2 cells likewise stimulated H2-free aerobic growth when separated from H. cinaedi by a Transwell barrier (see Fig. S1 in the supplemental material). Spent Caco-2 supernatant promoted mild growth enhancement, while boiling the spent media did not abolish this effect (Fig. S2). From these observations, we suspected that a diffusible metabolite—produced in common by the monolayers—was responsible (at least in part) for the altered atmospheric requirements.
l-Lactate supplementation.
To identify potential growth-promoting metabolites, 40 amino acids and short-chain carboxylates were next screened (10 mM each) for their effect on the H. cinaedi type strain under sequential microaerobic and aerobic atmospheres (see Materials and Methods for procedural specifics). Microaerobic and aerobic growth enhancement at 24 h was noted for several supplements, including pyruvate, propionate, acetate, and serine (confirmed in additional experimental replicates), although the effect of l-lactate (but not d-lactate) was most prominent (Fig. 2). Note that unsupplemented F12 medium contains a low concentration of pyruvate (1 mM) and serine (0.1 mM) but none of the other growth-promoting molecules. The molecules promoting aerobic growth were also tested in pairwise combinations (5 mM each), although they demonstrated no synergistic effects above 10 mM l-lactate alone. l-Lactate concentration was varied in subsequent trials, employing the same microaerobic-to-aerobic experimental strategy. In these experiments, growth promotion was observed at 24/48 h in both atmospheres with as little as 1 mM supplementation (Fig. 3A). Once aerobic growth was achieved, it continued in l-lactate supplemented F12 for multiple subcultures and was lost upon the molecule's removal (see Fig. S3 in the supplemental material). These results demonstrate that, in the proper context, the organism can proliferate without H2 under ambient oxygen levels.
FIG 2.
Growth promotion screen. Microaerobic and aerobic growth promotion was evaluated at 24 h in F12 medium supplemented with a 10 mM concentration of the indicated molecule or 5 mM each when two molecules are listed in combination (l-lactate [Lac], pyruvate [Pyr], serine [Ser], and propionate [Prop]). Every supplement was initially screened through two independent replicates (the average of which is plotted here). For conditions with increased growth, additional replicates were performed to confirm statistical significance compared to unsupplemented culture (n ≥ 4; P < 0.001 for both white and gray bars, except acetate [white bars only]).
FIG 3.
l-Lactate promotion of H. cinaedi growth. (A) Variable l-lactate concentration. The concentration of supplemental l-lactate (in F12 medium) was varied from 100 μM to 25 mM. For both H2-free/CO2-supplemented microaerobic and CO2-supplemented aerobic conditions, growth was assessed by OD600 measurement at 24 and 48 h (n = 4). With both atmospheres and time points, statistically significant increases in bacterial density (relative to unsupplemented) were noted for 1 mM l-lactate, with more-prominent changes at 10 and 25 mM (*, P < 0.001). (B) Effects of preceding culture conditions on aerobic growth. With 10 mM l-lactate supplementation, the stepwise transition from H2-free/CO2-supplemented microaerobic to CO2-supplemented aerobic conditions was systemically altered in four manners (as depicted in the figure and described in the text). For each daily subculture, bacteria were rediluted to an OD600 of 0.01 in monophasic F12. Final, aerobic OD600 values for each scenario at 24 h are depicted (gray bars), along with the corresponding lactate-free controls (white bars). Consistent aerobic growth promotion was observed for all scenarios (n = 4), except when bacteria were transitioned directly from lactate-free media under H2-supplemented microaerobic conditions to lactate-containing media under CO2-supplemented aerobic conditions. Here, aerobic bacterial growth was observed only in certain replicates, as indicated by prominent error bars indicated by the number sign.
It is important to emphasize that the above-described experiments utilized the same stepwise transition from microaerobic to aerobic conditions as described previously: preliminary growth, l-lactate-free F12, H2-supplemented microaerobic atmosphere; experimental day 1, l-lactate-supplemented F12, H2-free/CO2-supplemented microaerobic atmosphere; experimental day 2, l-lactate-supplemented F12, CO2-supplemented aerobic atmosphere. We therefore investigated whether the specific parameters of this transition affected the ability of l-lactate to promote aerobic growth. Variations were made to the above protocol, including (i) H2-supplemented versus H2-free/CO2-supplemented microaerobic atmosphere on experimental day 1 and (ii) l-lactate supplementation during initial microaerobic conditions (experimental day 1) versus l-lactate addition concurrent to the aerobic transition (experimental day 2). For each possible transition (denoted I to IV), the final levels of 24-h aerobic growth after day 2 are summarized in Fig. 3B. As long as the initial microaerobic culture on experimental day 1 included either CO2 or l-lactate supplementation, aerobic growth was observed in all experimental replicates. The organism demonstrated variable behavior, however, when l-lactate was added at the same time as the transition from an H2-supplemented microaerobic atmosphere. Here, aerobic growth was observed in certain replicates but not in others (evident by the large error bars). The latter data were from experiments with monophasic media, although an identical pattern occurred in biphasic F12, with proliferation in only some replicates (see Fig. S4 in the supplemental material). Overall, these findings indicate that, while l-lactate can support H2-free aerobic growth, the preceding environment influences the transition to this growth regimen.
Finally, several additional experiments were conducted to further define the environmental requirements of the phenomenon. Most notably, aerobic proliferation with l-lactate was dependent on the presence of CO2, as no growth was observed under 20% O2–80% N2, even in HEPES-buffered F12 (which does not require ambient CO2 to maintain neutral pH; Fig. 4). In this light, CO2 might serve as an anaplerotic carbon source under aerobic conditions. In contrast, aerobic proliferation of H. cinaedi was not observed on the surfaces of l-lactate-supplemented F12 agar plates, regardless of the presence of CO2 (not shown). The molecule also failed to promote growth under anaerobic conditions, for which optical density remained static or increased only slightly in both supplemented and unsupplemented F12 (see Fig. S5 in the supplemental material).
FIG 4.

CO2 requirement for aerobic growth. H. cinaedi ATCC BAA-847T was propagated in F12 medium buffered with either bicarbonate or HEPES. Following preculture in the respective medium with (+) 10 mM l-lactate under H2-free/CO2-supplemented microaerobic conditions, the bacteria were subcultured to an OD600 of 0.01 and propagated in the same medium under various atmospheres (n = 3). In the absence of CO2, neither the bicarbonate–buffered culture nor the HEPES-buffered culture was able to proliferate aerobically at 24 h in the presence of l-lactate (*, P < 0.001 relative to each of the other two conditions [white and gray bars]).
Aerobic growth of clinical isolates.
As the above-described experiments were conducted with the H. cinaedi type strain, we sought to confirm the phenomena with additional clinical isolates. Twelve human-derived strains were screened for their ability to proliferate aerobically in the presence of Caco-2 cells and l-lactate. Following initial culture in F12 medium under H2-supplemented microaerobic conditions, all clinical strains proliferated when inoculated directly onto Caco-2 monolayers under CO2-supplemented aerobic conditions, while no aerobic growth was observed during monoculture in F12 (Fig. 5A). For experiments with l-lactate, the same four microaerobic-to-aerobic transitions previously used for studies of the type strain were repeated. Summarized in Fig. 5B, all 12 strains continued to proliferate aerobically when precultured with l-lactate (10 mM) under H2-free/CO2-supplemented microaerobic conditions. In comparison, only certain strains grew aerobically if l-lactate presupplementation was omitted or if the aerobic transition occurred directly from an H2-supplemented microaerobic environment (see the legend to Fig. 5B for specific details). These observations further emphasize that the preceding environmental conditions impact the transition of H. cinaedi to an H2-independent aerotolerant state.
FIG 5.
Growth of clinical H. cinaedi strains. (A) Caco-2 coculture. Using the same experimental approach employed for the type strain (Fig. 1D), 12 additional human-derived strains of H. cinaedi were screened for aerobic growth promotion by Caco-2 cells. For all strains, aerobic growth was observed at 24 h for cocultured bacteria [F12 (+) Caco-2], but not corresponding monoculture controls [F12 (−) Caco-2]. Each bar represents a single replicate. (B) Aerobic growth promotion by l-lactate. The 12 clinical strains were likewise cultured with 10 mM l-lactate (in F12) and screened for growth in a CO2-supplemented aerobic atmosphere. As with the H. cinaedi type strain, several stepwise transitions of media and atmosphere were evaluated (with or without l-lactate preculture, with or without H2 preculture). These are indicated as transitions I to IV, as defined for the type strain in Fig. 3B. For each strain/transition, 24-h OD600 values are depicted for the final aerobic cultures. Two l-lactate-free negative controls are likewise included for each strain: aerobic growth in F12 following preculture in H2-supplemented microaerobic (Neg. Control 1) and H2-free/CO2-supplemented microaerobic (Neg. Control 2) conditions. All data points represent the averages of two independent replicates. When first cultured with l-lactate under an H2-free/CO2-supplemented microaerobic atmosphere (transition I), all 12 strains consistently proliferated following the aerobic transition. Only a portion of the strains continued to proliferate aerobically, however, if the preceding microaerobic environment failed to include l-lactate (transitions II and IV) or was supplemented with H2 (transitions III and IV).
Differential transcription analysis.
To investigate the organism's physiology during microaerobic and aerobic growth, H. cinaedi was next subjected to whole-transcriptome profiling. High-throughput RNA sequencing (RNA-seq) was performed on the type strain for various conditions of bacterial monoculture and epithelial coculture (unless noted, monophasic medium is implied): (condition 1) F12, H2-supplemented microaerobic (n = 4); (condition 2) biphasic F12, H2-supplemented microaerobic (n = 4); (condition 3) biphasic F12, H2-free/CO2-supplemented microaerobic (n = 4); (condition 4) F12 plus Caco-2 cells, H2-supplemented microaerobic (n = 5); (condition 5) F12 plus Caco-2 cells, aerobic (n = 5); (condition 6) F12 plus 10 mM l-lactate, H2-supplemented microaerobic (n = 4); (condition 7) F12 plus 10 mM l-lactate, aerobic (n = 4); and (condition 8) MHB, H2-supplemented microaerobic (n = 4). Expression levels for protein encoding open reading frames (ORFs) were calculated with the EDGE-pro software package for prokaryotic transcriptomics (37).
The distribution of RPKM values (reads per kilobase transcript per million reads), averaged across all conditions/replicates, is summarized as a histogram in Fig. 6. Several genes of interest are denoted explicitly in Fig. 6 and discussed in the following paragraphs. RPKM values for each gene—averaged across all culture conditions—were ranked by top abundance. The 25 highest values are summarized in Table S1 in the supplemental material, with a complete ordered list provided in Data Set S1 in the supplemental material. Many of the most abundant genes served clear housekeeping (ATP synthase, GroEL, and EF-Tu) or antioxidative (alkyl hydroperoxide reductase, peroxiredoxin, and superoxide dismutase) roles. For several other transcripts, however, prominent expression was unanticipated, and their specific physiologic roles remain to be determined. These transcripts include the hcp component of a predicted type VI secretion locus (ORF 1435), as well as two proteins with predicted signal peptides but lacking any homologues of known function (ORFs 542 and 1720).
FIG 6.
Distribution of transcript levels across the H. cinaedi genome. For each predicted gene in H. cinaedi ATCC BAA-847T, RPKM values (reads per kilobase transcript per million reads mapped) were calculated. The distribution of these values—averaged across the 8 culture conditions and 34 biologic replicates—is plotted here for the 2,321 predicted protein-encoding ORFs. Values have been converted to a log10 scale, with a bin width of 0.1. RPKM values for several genes discussed in the text are indicated explicitly. These include genes encoding components of respiratory nitrate reductase under both Caco-2/l-lactate supplemented (NO3− Red., Supp.) and unsupplemented (NO3− Red., Unsupp.) conditions (further summarized in Table 3), components of the lactate utilization operon (lctP and lldE [Table 4]), and the organism's most abundant protein-encoding transcripts (see Table S1 in the supplemental material).
In Fig. 7A, relative transcription of each gene is illustrated as a heatmap according to the experimental condition and its position in the genome. From these data, expression levels were compared on a gene-by-gene basis through DESeq-2 (41). Differentially expressed genes were determined for the various pairwise combinations of the eight culture conditions. For the purposes of this discussion, a gene is considered differentially expressed if its detection changed >2-fold between conditions with an adjusted P value of <0.001. For each condition-condition comparison, the number of differentially expressed genes (out of 2,368 in the genome) is summarized in Fig. 7B; complete lists of these genes are provided in Data Set S2 in the supplemental material. Of particular interest are genes that were differentially expressed with Caco-2 and l-lactate supplementation (conditions 4 to 7) relative to all other conditions with unsupplemented F12 and MHB (conditions 1, 3, 5, and 8).
FIG 7.

Differential transcription across culture conditions. (A) Relative transcriptional abundance for each gene and culture condition. RNA-seq transcript levels for each ORF in H. cinaedi ATCC BAA-847T are summarized across eight culture conditions as follows (conditions 1 to 8 indicated by the numbers 1 to 8 within brackets): [1], monophasic F12, H2-supplemented microaerobic; [2], biphasic F12, H2-supplemented microaerobic; [3], biphasic F12, H2-free/CO2-supplemented microaerobic; [4], F12 plus Caco-2 cells, H2-supplemented microaerobic; [5], F12 plus Caco-2 cells, aerobic; [6], F12 plus 10 mM l-lactate, H2-supplemented microaerobic; [7], F12 plus 10 mM l-lactate, aerobic; [8], MHB, H2-supplemented microaerobic. Rows of the heatmap correspond to individual genes (in sequential order), while columns denote culture conditions. Average RPKM values for each gene/condition are designated according to log2 values. (B) Differentially expressed genes. Transcription levels of all genes were compared among the above culture conditions in a pairwise manner. The matrix summarizes the number of differentially transcribed genes between the stated conditions (in the column and row headers). A complete list of these genes for each comparison is included in Data Set S2 in the supplemental material.
For these 16 pairwise comparisons (conditions 4 to 7 versus conditions 1, 3, 5, and 8), the overlapping set of differentially expressed genes was limited to two loci, a putative six-gene operon (ORFs 1272 to 1277) encoding the components of a Nap class periplasmic nitrate reductase (napAGHBLD) and a two-gene operon (ORFs 2132 and 2133) encoding a putative trimethylamine-N-oxide/dimethyl sulfoxide (TMAO/DMSO). Mean RPKM values for these genes across all eight conditions are summarized in Table 3 and denoted in Fig. 5. Nap class enzymes are distinct from Nar class nitrate reductases that generate a proton motive force in various proteobacteria as alternate terminal electron acceptors (Nap enzymes are notably absent from the epsilonproteobacterial subdivision) (43). Nevertheless, periplasmic nitrate reductases may still participate indirectly in anaerobic respiration, as well as other processes in dissimilitatory nitrogen metabolism (44–46). In Escherichia coli, the nap operon is preferentially expressed during anaerobic, low-nitrate conditions and is additionally regulated by cyclic AMP (cAMP)-mediated catabolite repression (47). In H. cinaedi, by contrast, observed transcription of these genes decreased significantly (up to ∼10-fold) in the presence of Caco-2 cells or l-lactate, whether in an H2-enhanced microaerobic atmosphere (conditions 4 and 6) or an aerobic atmosphere (conditions 5 and 7). ORF 2132 is homologous to the torA gene of Campylobacter jejuni, which likewise acts as an alternate terminal electron acceptor through the reduction of TMAO/DMSO (48). Although the altered expression levels of these operons in H. cinaedi do not elucidate the underlying mechanism of aerobic growth per se, they suggest an organism whose redox physiology is adapted to multiple atmospheric/nutritional environments.
TABLE 3.
RNA-seq analysis of periplasmic nitrate reductase and TMAO/DMSO reductase genes
| Conditiona | Mean RPKM value |
|||||||
|---|---|---|---|---|---|---|---|---|
| Periplasmic nitrate reductaseb |
TMAO/DMSO reductasec |
|||||||
| napA | napG | napH | napB | napL | napD | torA | ORF 2133 | |
| 1 | 2,377 | 1,815 | 1,021 | 1,046 | 261 | 255 | 679 | 464 |
| 2 | 3,305 | 2,483 | 1,392 | 1,384 | 376 | 224 | 1,135 | 892 |
| 3 | 3,060 | 2,629 | 1,357 | 1,284 | 242 | 136 | 1,289 | 543 |
| 4* | 341 | 297 | 168 | 153 | 54 | 29 | 102 | 33 |
| 5* | 333 | 327 | 195 | 186 | 79 | 51 | 83 | 36 |
| 6* | 158 | 169 | 78 | 99 | 36 | 33 | 141 | 60 |
| 7* | 243 | 261 | 120 | 133 | 54 | 40 | 104 | 41 |
| 8 | 2,792 | 2,724 | 1,142 | 1,307 | 376 | 169 | 2,775 | 920 |
Atmosphere and media of the given culture condition, as defined by conditions 1 to 8 in the body of the text and in the legend to Fig. 7. Caco-2 and l-lactate-supplemented conditions (conditions 4 to 7) are indicated with an asterisk; note downregulation of both operons for these conditions, relative to conditions 1 to 3 and 8.
Analysis of l-lactate utilization genes.
The genes responsible for l-lactate utilization were recently characterized in two species of Epsilonproteobacteria, Helicobacter pylori (49) and C. jejuni (50). In both organisms, l-lactate permease (LctP) is encoded divergently from a three-gene segment that includes putative iron-sulfur clusters and comprises a nonfermentative l-lactate dehydrogenase (iLDH). These enzymes are distinct from classic NAD-dependent lactate dehydrogenases, which interconvert l-lactate and pyruvate during fermentative metabolism (51). Instead, iLDH generates pyruvate from l-lactate (typically in an NAD-independent fashion) and can potentially serve as a respiratory electron donor. The LctP/iLDH element in H. pylori and C. jejuni is conserved broadly among many Gram-positive and Gram-negative species, and it was first characterized in Bacillus subtilis (as the lut operon) (52) and Shewanella oneidensis (53).
As depicted in Fig. S6 in the supplemental material, H. cinaedi encodes a similar element with putative genes for LctP and iLDH from ORFs 304 to 307 (denoted here as lctP and lldEFG, keeping with the H. pylori nomenclature). The current RNA-seq analysis revealed prominent transcription of both lctP and lldEFG, with RPKM values ranging (per condition) from 1.27 × 103 to 6.40 × 103 for lctP and 4.7 × 102 to 2.3 × 103 for the lld components (Table 4). Across all culture conditions/replicates, observed coverage of these genes fell within the top 15% of all protein-encoding ORFs in the organism's genome. At the same time, only mild differential expression of lctP and lld (less than a twofold change) was observed between most conditions. Upregulation of lctP was noted for bacteria grown with biphasic media (conditions 2 and 3), although the significance of this observation is unclear (for condition 3, an additional contributing factor could be the H2-free/CO2-supplemented microaerobic atmosphere). The lack of more-pronounced transcriptional changes during l-lactate supplementation is perhaps surprising; to our knowledge, similar transcriptional studies of this locus have not been conducted in other epsilonproteobacteria. Nevertheless, the current results suggest strong constitutive transcription of l-lactate utilization machinery and a prominent role for this nutrient in the natural physiology of H. cinaedi.
TABLE 4.
RNA-seq analysis of the l-lactate utilization locus
| Conditiona | Mean RPKM valueb |
|||
|---|---|---|---|---|
| lldG | lldF | lldE | lctP | |
| 1 | 1,059 | 1,259 | 1,031 | 1,706 |
| 2 | 1,114 | 1,463 | 1,662 | 5,534 |
| 3 | 1,036 | 1,907 | 2,329 | 6,395 |
| 4* | 909 | 1,295 | 1,189 | 1,309 |
| 5* | 1,232 | 1,735 | 1,557 | 2,157 |
| 6* | 685 | 1,791 | 1,608 | 1,356 |
| 7* | 923 | 1,934 | 1,566 | 1,562 |
| 8 | 468 | 922 | 966 | 1,266 |
Atmosphere and media of the given culture condition, as defined by numbers 1 to 8 in the body of the text and the legend to Fig. 7. Caco-2 and l-lactate-supplemented conditions are indicated with an asterisk.
Mean RPKM values of l-lactate dehydrogenase component lldG (ORF 304), l-lactate dehydrogenase component lldF (ORF 305), l-lactate dehydrogenase component lldE (ORF 306), and l-lactate permease, lctP (ORF 307) are shown.
Coexpression analysis.
To evaluate global transcriptional relationships, coexpression analysis was conducted across all biological replicates and culture conditions. This includes the eight scenarios described above, as well as H. cinaedi grown under H2-supplemented microaerobic conditions in F12 medium supplemented with 10% human serum (n = 5). The latter condition was excluded from the previous analyses due to citrate supplementation of the serum (as a chelating agent), confounding the influence of the serum itself on bacterial physiology. RPKM-based Pearson coefficients (ri,j) were calculated for each gene-gene pair, summarized in Fig. 8 as a hierarchically clustered heatmap. Data Set S3 in the supplemental material includes a complete list of gene-gene pairs with prominent coexpression (|ri,j| > x, with analyses provided for x = 0.7 and 0.8); a file with all pairwise Pearson coefficients and corresponding P values is available for download via figshare [see “Accession number(s)” above].
FIG 8.
Transcriptional coexpression analysis. RPKM-based Pearson coefficients were calculated for each gene-gene pair in the H. cinaedi genome, with absolute values (abs) summarized here as a heatmap. Green clusters represent genes with high coexpression trends (either positive or negative).
For several genes discussed above, napA and lctP, coexpression partners are summarized explicitly in Tables S2 and S3 in the supplemental material. For napA, this includes inverse correlation with an operon encoding a molybdenum-binding periplasmic protein and ABC transporter (ORFs 299 to 302), appropriate given that periplasmic nitrate reductases are known molybdoenzymes. Strong positive correlation was observed between transcription of lctP and several enzymes of central carbon metabolism (e.g., pyruvate:ferredoxin oxidoreductase [ORF 403/405], acetate kinase [ORF 2183], and acetyl coenzyme A [acetyl-CoA] synthetase [ORF 1787]), as well as additional carbon uptake proteins. The latter include a putative acetate permease (ORF 523), serine transporter (ORF 58), alanine transporter (ORF 1209), and carbon starvation protein A (ORF 861). Of note, both acetate and serine demonstrated a mild aerobic growth-promoting effect in the initial supplement screen of Fig. 2. Together, these correlations further suggest that lctP is a central component in the organism's network of nutrient acquisition and metabolism, in response to changing environmental milieus.
DISCUSSION
The work presented here demonstrates that H. cinaedi is not exclusively dependent on H2-enhanced microaerobic conditions for proliferation. Epithelial monolayers, l-lactate (given the appropriate preculture conditions), and FBS (variably) all have the potential to support H2-free aerobic growth of this species. Practically speaking, we recommend the following approach for propagating H. cinaedi in liquid culture without the use of supplemental H2 gas. Under CO2-supplemented microaerobic conditions (i.e., commercial sachets), either serum-supplemented brucella broth or l-lactate-supplemented F12 medium can be employed. The latter medium can then be transitioned to CO2-supplemented aerobic conditions for further subculture.
The basic phenomenon of microaerophilicity, generally attributed to oxidative stress tolerance (54), has still not been characterized in full. Our findings challenge the traditional paradigm that many epsilonproteobacteria are invariably microaerophilic, instead demonstrating that the atmospheric and small-molecule requirements of H. cinaedi are interconnected. This phenomenon has implications for improving in vitro culture methodologies and increasing our understanding of H. cinaedi metabolism during infection. The ability to work with this organism under aerobic conditions could represent a useful tool, particularly in clinical laboratories—where H2-supplemented microaerobic environments are not universally employed—or when high quantities/concentrations of H2 are not desired for safety reasons. In general, l-lactate might serve as a nutritional supplement for H. cinaedi propagation. One could likewise hypothesize a role for l-lactate metabolism during H. cinaedi infections, especially given the relative abundance of l-lactate in blood and tissue as an endpoint of eukaryotic nonrespiratory metabolism. Although the gut is characterized by low O2 levels and flora-generated H2 (29), the same is not true of the bloodstream or peripheral soft tissue. At these extraintestinal sites of infection where H2 levels are low/absent, l-lactate could serve as an important host-derived metabolite. Additional studies will be needed to test these hypotheses.
As described in Results (see “Analysis of l-lactate utilization genes”), other members of the Epsilonproteobacteria likewise possess the ability to utilize l-lactate as a carbon source. Although l-lactate metabolism has not previously been investigated in the context of atmospheric requirements, limited previous work has demonstrated that C3- and C4-carboxylates (in particular, pyruvate and fumarate) can improve the aerobic growth of C. jejuni (55, 56). Otherwise, the relationship between nutrients and ambient gas in the epsilonproteobacteria remain poorly defined. In future work, it will be of interest to test the ability of l-lactate to promote aerobic growth of other species of the class, especially emerging pathogens whose cultivation is difficult without supplemental H2 (e.g., Campylobacter concisus, Helicobacter fennelliae) (27). The current work has less potential relevance to cultivation of the gastric pathogen Helicobacter pylori, which does not demonstrate a strong H2 dependence and exhibits only scant growth in F12 medium, modestly enhanced by supplemental cholesterol (57). In preliminary experiments (unpublished), l-lactate failed to enhance H. pylori proliferation under aerobic or microaerobic conditions. At the same time, it is noteworthy that several reports have highlighted that H. pylori is not invariably microaerobic (58, 59). Although unrelated to l-lactate, the ability to propagate certain strains of H. pylori under aerobic conditions (in serum-supplemented, complex media with sufficient CO2 supplementation) is routinely exploited within many research laboratories.
The underlying mechanism by which l-lactate induces aerotolerance in H. cinaedi likewise requires additional study. The organism's alternate growth conditions might reflect its energetic/carbon source requirements and the various biochemical combinations that satisfy them (for instance, H2 gas versus lactate as a respiratory electron donor). In this regard, H2-free aerobic growth was promoted to a lesser degree by several other small molecules (e.g., pyruvate, serine), all metabolites interconvertible with l-lactate by one or two enzymatic reactions. Notably, whereas l-lactate-induced aerobiosis variably required microaerobic presupplementation, growth was universally observed when H. cinaedi was transitioned from microaerobic monoculture to aerobic epithelial coculture. It is certainly possible that the growth-promoting effect of epithelial cells is attributable to multiple factors, as the relationship between H. cinaedi and epithelial cells is potentially complex. This is underscored by recently published data on the physical interactions between the organism and polarized Caco-2 monolayers (60). Although that study did not address the phenomenon of induced aerobic growth, it reported the ability of H. cinaedi to adhere to, invade, and translocate across the cells.
Finally, the current RNA-seq data support the importance of l-lactate as an H. cinaedi nutrient, as well as the organism's potential respiratory flexibility. The l-lactate utilization locus demonstrated prominent transcription across culture conditions, along with strong coexpression trends with other nutrient acquisition proteins and enzymes of central carbon metabolism. In addition, supplemental l-lactate and Caco-2 cells significantly downregulated transcription of respiratory electron acceptors, namely, a periplasmic nitrate reductase and TMAO/DMSO reductase. Future work might be able to evaluate the organism's metabolism, as well as its transcriptional regulation, in the context of a colonized/infected mammalian host. In general, RNA-seq represents a valuable method both to generate and test hypotheses for organisms like H. cinaedi, where extensive methods for genetic manipulation are currently lacking.
To conclude, the present work demonstrates context-dependent atmospheric requirements for H. cinaedi, an emerging opportunistic pathogen of diverse anatomic sites whose fastidious growth can hinder both laboratory diagnosis and investigative efforts. Going forward, a greater understanding of this organism's metabolism could shed light on its enigmatic pathogenesis and optimize methods for identifying cases of infection.
Supplementary Material
ACKNOWLEDGMENTS
We thank James Fox of the Massachusetts Institute of Technology for helpful insights and assistance with bacterial strains, as well as the Vanderbilt Institute for Clinical and Translational Research (VICTR) for facilitating consultation on this project.
The Vanderbilt Institute for Clinical and Translational Research is supported by grant UL1TR000445 from the National Center for Advancing Translational Sciences.
Funding Statement
This work, including the efforts of Jonathan E. Schmitz, was funded by the Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine (Clinical and Translational Research Enhancement Award). This work, including the efforts of Timothy L. Cover, was funded the Vanderbilt Digestive Diseases Research Center (VDDRC). The VDDRC is supported by HHS | National Institutes of Health (NIH) (P30DK058404).
Footnotes
Supplemental material for this article may be found at http://dx.doi.org/10.1128/AEM.01943-16.
REFERENCES
- 1.Totten PA, Fennell CL, Tenover FC, Wezenberg JM, Perine PL, Stamm WE, Holmes KK. 1985. Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis 151:131–139. doi: 10.1093/infdis/151.1.131. [DOI] [PubMed] [Google Scholar]
- 2.Grayson ML, Tee W, Dwyer B. 1989. Gastroenteritis associated with Campylobacter cinaedi. Med J Aust 150:214–215. [DOI] [PubMed] [Google Scholar]
- 3.Cimolai N, Gill MJ, Jones A, Flores B, Stamm WE, Laurie W, Madden B, Shahrabadi MS. 1987. “Campylobacter cinaedi” bacteremia: case report and laboratory findings. J Clin Microbiol 25:942–943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Tee W, Street AC, Spelman D, Munckhof W, Mijch A. 1996. Helicobacter cinaedi bacteraemia: varied clinical manifestations in three homosexual males. Scand J Infect Dis 28:199–203. doi: 10.3109/00365549609049078. [DOI] [PubMed] [Google Scholar]
- 5.Kiehlbauch JA, Tauxe RV, Baker CN, Wachsmuth IK. 1994. Helicobacter cinaedi-associated bacteremia and cellulitis in immunocompromised patients. Ann Intern Med 121:90–93. doi: 10.7326/0003-4819-121-2-199407150-00002. [DOI] [PubMed] [Google Scholar]
- 6.Burman WJ, Cohn DL, Reves RR, Wilson ML. 1995. Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. Clin Infect Dis 20:564–570. doi: 10.1093/clinids/20.3.564. [DOI] [PubMed] [Google Scholar]
- 7.Okubo H, Goto M, Sato M, Sugiyama T, Kawano M, Matsunaga T, Akaike T. 2014. Helicobacter cinaedi meningitis: a case report and review of previous cases. J Neurol Sci 347:396–397. doi: 10.1016/j.jns.2014.10.011. [DOI] [PubMed] [Google Scholar]
- 8.Maki Y, Furukawa S, Kodama Y, Sumiyoshi K, Kino E, Sameshima H. 2016. Preterm labor and neonatal sepsis caused by intrauterine Helicobacter cinaedi infection. J Infect Chemother 22:414–416. doi: 10.1016/j.jiac.2015.12.008. [DOI] [PubMed] [Google Scholar]
- 9.Nielsen HL, Prag J, Krogfelt KA. 6 October 2015. Helicobacter cinaedi knee infection after arthroscopy in an immunocompetent patient. BMJ Case Rep 2015:pii=bcr2014208637. doi: 10.1136/bcr-2014-208637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sacks LV, Labriola AM, Gill VJ, Gordin FM. 1991. Use of ciprofloxacin for successful eradication of bacteremia due to Campylobacter cinaedi in a human immunodeficiency virus-infected person. Rev Infect Dis 13:1066–1068. doi: 10.1093/clinids/13.6.1066. [DOI] [PubMed] [Google Scholar]
- 11.Decker CF, Martin GJ, Barham WB, Paparello SF. 1992. Bacteremia due to Campylobacter cinaedi in a patient infected with the human immunodeficiency virus. Clin Infect Dis 15:178–179. [DOI] [PubMed] [Google Scholar]
- 12.Murakami H, Goto M, Ono E, Sawabe E, Iwata M, Okuzumi K, Yamaguchi K, Takahashi T. 2003. Isolation of Helicobacter cinaedi from blood of an immunocompromised patient in Japan. J Infect Chemother 9:344–347. doi: 10.1007/s10156-003-0265-3. [DOI] [PubMed] [Google Scholar]
- 13.Simons E, Spacek LA, Lederman HM, Winkelstein JA. 2004. Helicobacter cinaedi bacteremia presenting as macules in an afebrile patient with X-linked agammaglobulinemia. Infection 32:367–368. doi: 10.1007/s15010-004-3152-7. [DOI] [PubMed] [Google Scholar]
- 14.Lasry S, Simon J, Marais A, Pouchot J, Vinceneux P, Boussougant Y. 2000. Helicobacter cinaedi septic arthritis and bacteremia in an immunocompetent patient. Clin Infect Dis 31:201–202. doi: 10.1086/313930. [DOI] [PubMed] [Google Scholar]
- 15.Van Genderen PJ, Goessens WH, Petit PL. 2005. Helicobacter cinaedi-associated bacteraemia and erysipelas in an immunocompetent host: a diagnostic challenge. Scand J Infect Dis 37:382–385. [DOI] [PubMed] [Google Scholar]
- 16.Bartels H, Goldenberger D, Reuthebuch O, Vosbeck J, Weisser M, Frei R, Bättig V. 2014. First case of infective endocarditis caused by Helicobacter cinaedi. BMC Infect Dis 14:586. doi: 10.1186/s12879-014-0586-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Haruki Y, Hagiya H, Hashimoto T, Miyake T, Murase T, Matsuo A, Sugiyama T, Kondo S. 2015. Pyogenic spondylitis and diskitis caused by Helicobacter cinaedi in an immunocompetent adult patient. Intern Med 54:2415–2418. doi: 10.2169/internalmedicine.54.4726. [DOI] [PubMed] [Google Scholar]
- 18.Kitamura T, Kawamura Y, Ohkusu K, Masaki T, Iwashita H, Sawa T, Fujii S, Okamoto T, Akaike T. 2007. Helicobacter cinaedi cellulitis and bacteremia in immunocompetent hosts after orthopedic surgery. J Clin Microbiol 45:31–38. doi: 10.1128/JCM.01507-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Oyama K, Khan S, Okamoto T, Fujii S, Ono K, Matsunaga T, Yoshitake J, Sawa T, Tomida J, Kawamura Y, Akaike T. 2012. Identification of and screening for human Helicobacter cinaedi infections and carriers via nested PCR. J Clin Microbiol 50:3893–3900. doi: 10.1128/JCM.01622-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kiehlbauch JA, Brenner DJ, Cameron DN, Steigerwalt AG, Makowski JM, Baker CN, Patton CM, Wachsmuth IK. 1995. Genotypic and phenotypic characterization of Helicobacter cinaedi and Helicobacter fennelliae strains isolated from humans and animals. J Clin Microbiol 33:2940–2947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Taniguchi T, Sekiya A, Higa M, Saeki Y, Umeki K, Okayama A, Hayashi T, Misawa N. 2014. Rapid identification and subtyping of Helicobacter cinaedi strains by intact-cell mass spectrometry profiling with the use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 52:95–102. doi: 10.1128/JCM.01798-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Shen Z, Feng Y, Rogers AB, Rickman B, Whary MT, Xu S, Clapp KM, Boutin SR, Fox JG. 2009. Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice. Infect Immun 77:2508–2516. doi: 10.1128/IAI.00166-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Charoenlap N, Shen Z, McBee ME, Muthupalani S, Wogan GN, Fox JG, Schauer DB. 2012. Alkyl hydroperoxide reductase is required for Helicobacter cinaedi intestinal colonization and survival under oxidative stress in BALB/c and BALB/c interleukin-10−/− mice. Infect Immun 80:921–928. doi: 10.1128/IAI.05477-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kawamura Y, Tomida J, Morita Y, Fujii S, Okamoto T, Akaike T. 2014. Clinical and bacteriological characteristics of Helicobacter cinaedi infection. J Infect Chemother 20:517–526. doi: 10.1016/j.jiac.2014.06.007. [DOI] [PubMed] [Google Scholar]
- 25.American Type Culture Collection. Helicobacter cinaedi (Totten et al.) Vandamme et al. (ATCC® BAA847™). Product sheet. American Type Culture Collection, Manassas, VA: http://www.atcc.org/Products/All/BAA-847.aspx#documentation Accessed 22 September 2015. [Google Scholar]
- 26.Tomida J, Oumi A, Okamoto T, Morita Y, Okayama A, Misawa N, Hayashi T, Akaike T, Kawamura Y. 2013. Comparative evaluation of agar dilution and broth microdilution methods for antibiotic susceptibility testing of Helicobacter cinaedi. Microbiol Immunol 57:353–358. doi: 10.1111/1348-0421.12044. [DOI] [PubMed] [Google Scholar]
- 27.Lastovica AJ. 2006. Emerging Campylobacter spp.: the tip of the iceberg. Clin Microbiol Newsl 28(7):49–55. doi: 10.1016/j.clinmicnews.2006.03.004. [DOI] [Google Scholar]
- 28.Powers-Fletcher MV, Couturier MR. 2015. Non-Helicobacter pylori Helicobacter species associated with human disease: a primer for the clinical microbiology laboratory. Clin Microbiol Newsl 37:93–101. doi: 10.1016/j.clinmicnews.2015.05.004. [DOI] [Google Scholar]
- 29.Benoit SL, Maier RJ. 2008. Hydrogen and nickel metabolism in Helicobacter species. Ann N Y Acad Sci 1125:242–251. doi: 10.1196/annals.1419.014. [DOI] [PubMed] [Google Scholar]
- 30.Araoka H, Baba M, Kimura M, Abe M, Inagawa H, Yoneyama A. 2014. Clinical characteristics of bacteremia caused by Helicobacter cinaedi and time required for blood cultures to become positive. J Clin Microbiol 52:1519–1522. doi: 10.1128/JCM.00265-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Miyake N, Chong Y, Nishida R, Nagasaki Y, Kibe Y, Kiyosuke M, Shimomura T, Shimono N, Shimoda S, Akashi K. 2015. A dramatic increase in the positive blood culture rates of Helicobacter cinaedi: the evidence of differential detection abilities between the Bactec and BacT/Alert systems. Diagn Microbiol Infect Dis 83:232–233. doi: 10.1016/j.diagmicrobio.2015.07.017. [DOI] [PubMed] [Google Scholar]
- 32.Matsumoto T, Goto M, Murakami H, Tanaka T, Nishiyama H, Ono E, Okada C, Sawabe E, Yagoshi M, Yoneyama A, Okuzumi K, Tateda K, Misawa N, Yamaguchi K. 2007. Multicenter study to evaluate bloodstream infection by Helicobacter cinaedi in Japan. J Clin Microbiol 45:2853–2857. doi: 10.1128/JCM.00465-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Wilson ML, Weinstein MP, Reller LB. 2016. Commercial blood culture systems and methods, p 11–20. In Truant AL, Tang Y, Waites KB, Béb́ear C, Rennie RP (ed), Manual of commercial methods in clinical microbiology: international edition, 2nd ed John Wiley & Sons, Inc, Hoboken, NJ. [Google Scholar]
- 34.Uwamino Y, Muranaka K, Hase R, Otsuka Y, Hosokawa N. 2016. Clinical features of community-acquired Helicobacter cinaedi bacteremia. Helicobacter 21:24–28. doi: 10.1111/hel.12236. [DOI] [PubMed] [Google Scholar]
- 35.Miyoshi-Akiyama T, Takeshita N, Ohmagari N, Kirikae T. 2012. Complete genome sequence of Helicobacter cinaedi type strain ATCC BAA-847. J Bacteriol 194:5692. doi: 10.1128/JB.01347-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Blanchard TG, Nedrud JG. 2012. Laboratory maintenance of Helicobacter species. Curr Protoc Microbiol Chapter 8:Unit 8B.1. doi: 10.1002/9780471729259.mc08b01s24. [DOI] [PubMed] [Google Scholar]
- 37.Magoc T, Wood D, Salzberg SL. 2013. EDGE-pro: estimated degree of gene expression in prokaryotic genomes. Evol Bioinform Online 9:127–136. doi: 10.4137/EBO.S11250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Cuccuru G, Orsini M, Pinna A, Sbardellati A, Soranzo N, Travaglione A, Uva P, Zanetti G, Fotia G. 2014. Orione, a web-based framework for NGS analysis in microbiology. Bioinformatics 30:1928–1929. doi: 10.1093/bioinformatics/btu135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.R Core Team. 2016. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria: https://www.R-project.org. [Google Scholar]
- 40.Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, Liaw A, Lumley T, Maechler M, Magnusson A, Moeller S, Schwartz M, Venables B. 2016. gplots: various R programming tools for plotting data. Version 3.1. https://cran.r-project.org/web/packages/gplots/index.html.
- 41.Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. doi: 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Harrell FE, Dupont C, et al. 2016. Hmisc: Harrell Miscellaneous. R package version 3.17-4 https://CRAN.R-project.org/package=Hmisc.
- 43.Kern M, Simon J. 2009. Electron transport chains and bioenergetics of respiratory nitrogen metabolism in Wolinella succinogenes and other Epsilonproteobacteria. Biochim Biophys Acta 1787:646–656. doi: 10.1016/j.bbabio.2008.12.010. [DOI] [PubMed] [Google Scholar]
- 44.Stewart V, Lu Y, Darwin AJ. 2002. Periplasmic nitrate reductase (NapABC enzyme) supports anaerobic respiration by Escherichia coli K-12. J Bacteriol 184:1314–1323. doi: 10.1128/JB.184.5.1314-1323.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Weingarten RA, Grimes JL, Olson JW. 2008. Role of Campylobacter jejuni respiratory oxidases and reductases in host colonization. Appl Environ Microbiol 74:1367–1375. doi: 10.1128/AEM.02261-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Lopez CA, Rivera-Chávez F, Byndloss MX, Bäumler AJ. 2015. The periplasmic nitrate reductase NapABC supports luminal growth of Salmonella enterica serovar Typhimurium during colitis. Infect Immun 83:3470–3478. doi: 10.1128/IAI.00351-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Stewart V, Bledsoe PJ, Chen LL, Cai A. 2009. Catabolite repression control of napF (periplasmic nitrate reductase) operon expression in Escherichia coli K-12. J Bacteriol 191:996–1005. doi: 10.1128/JB.00873-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Sellars MJ, Hall SJ, Kelly DJ. 2002. Growth of Campylobacter jejuni supported by respiration of fumarate, nitrate, nitrite, trimethylamine-N-oxide, or dimethyl sulfoxide requires oxygen. J Bacteriol 184:4187–4196. doi: 10.1128/JB.184.15.4187-4196.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Iwatani S, Nagashima H, Reddy R, Shiota S, Graham DY, Yamaoka Y. 2014. Identification of the genes that contribute to lactate utilization in Helicobacter pylori. PLoS One 9:e103506. doi: 10.1371/journal.pone.0103506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Thomas MT, Shepherd M, Poole RK, van Vliet AH, Kelly DJ, Pearson BM. 2011. Two respiratory enzyme systems in Campylobacter jejuni NCTC 11168 contribute to growth on l-lactate. Environ Microbiol 13:48–61. doi: 10.1111/j.1462-2920.2010.02307.x. [DOI] [PubMed] [Google Scholar]
- 51.Zhao R, Zheng S, Duan C, Liu F, Yang L, Huo G. 2013. NAD-dependent lactate dehydrogenase catalyses the first step in respiratory utilization of lactate by Lactococcus lactis. FEBS Open Bio 3:379–386. doi: 10.1016/j.fob.2013.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Chai Y, Kolter R, Losick R. 2009. A widely conserved gene cluster required for lactate utilization in Bacillus subtilis and its involvement in biofilm formation. J Bacteriol 191:2423–2430. doi: 10.1128/JB.01464-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Pinchuk GE, Rodionov DA, Yang C, Li X, Osterman AL, Dervyn E, Geydebrekht OV, Reed SB, Romine MF, Collart FR, Scott JH, Fredrickson JK, Beliaev AS. 2009. Genomic reconstruction of Shewanella oneidensis MR-1 metabolism reveals a previously uncharacterized machinery for lactate utilization. Proc Natl Acad Sci U S A 106:2874–2879. doi: 10.1073/pnas.0806798106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kim JC, Oh E, Kim J, Jeon B. 2015. Regulation of oxidative stress resistance in Campylobacter jejuni, a microaerophilic foodborne pathogen. Front Microbiol 6:751. doi: 10.3389/fmicb.2015.00751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Verhoeff-Bakkenes L, Arends AP, Snoep JL, Zwietering MH, de Jonge R. 2008. Pyruvate relieves the necessity of high induction levels of catalase and enables Campylobacter jejuni to grow under fully aerobic conditions. Lett Appl Microbiol 46:377–382. doi: 10.1111/j.1472-765X.2008.02326.x. [DOI] [PubMed] [Google Scholar]
- 56.Hinton A., Jr 2013. Aerobic growth of Campylobacter in media supplemented with C3-monocarboxylates and C4-dicarboxylates. J Food Prot 76:685–690. doi: 10.4315/0362-028X.JFP-12-430. [DOI] [PubMed] [Google Scholar]
- 57.Testerman TL, McGee DJ, Mobley HL. 2001. Helicobacter pylori growth and urease detection in the chemically defined medium Ham's F-12 nutrient mixture. J Clin Microbiol 39:3842–3850. doi: 10.1128/JCM.39.11.3842-3850.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Bury-Moné S, Kaakoush NO, Asencio C, Mégraud F, Thibonnier M, De Reuse H, Mendz GL. 2006. Is Helicobacter pylori a true microaerophile? Helicobacter 11:296–303. doi: 10.1111/j.1523-5378.2006.00413.x. [DOI] [PubMed] [Google Scholar]
- 59.Park SA, Ko A, Lee NG. 2011. Stimulation of growth of the human gastric pathogen Helicobacter pylori by atmospheric level of oxygen under high carbon dioxide tension. BMC Microbiol 11:96. doi: 10.1186/1471-2180-11-96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Taniguchi T, Yamazaki W, Saeki Y, Takajo I, Okayama A, Hayashi T, Misawa N. 2016. The pathogenic potential of Helicobacter cinaedi isolated from nonhuman sources: adherence, invasion and translocation ability in polarized intestinal epithelial Caco-2 cells in vitro. J Vet Med Sci 78:627–632. doi: 10.1292/jvms.15-0595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Shen Z, Sheh A, Young SK, Abouelliel A, Ward DV, Earl AM, Fox JG. 2014. Draft genome sequences of six enterohepatic Helicobacter species isolated from humans and one from rhesus macaques. Genome Announc 2(5):e00857-14. doi: 10.1128/genomeA.00857-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






